Loading...

biote Corp.

BTMDNASDAQ
Healthcare
Medical - Care Facilities
$4.32
$0.16(3.85%)

biote Corp. (BTMD) Stock Overview

Explore biote Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.0/100

Key Financials

Market Cap165.4M
P/E Ratio6.21
EPS (TTM)$0.58
ROE-0.19%
Fundamental Analysis

AI Price Forecasts

1 Week$3.61
1 Month$4.76
3 Months$2.73
1 Year Target$6.00

BTMD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of biote Corp. (BTMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 6.21 and a market capitalization of 165.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;